Evidence map›Paper›PMID 25537517›Full record

ArticleOncotarget2015

Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival.

Bin Xu, Xiaobao Jin, Ling Min, Qin Li, Lulu Deng, Hui Wu, Guixian Lin, Lixin Chen, Haifeng Zhang, Chunmei Li and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. High Expression ofJournal of clinical medicine · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Bin XuGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Xiaobao JinGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Ling MinCancer Center of Guangzhou Medical University, Guangzhou, China.
Qin LiGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Lulu DengGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Hui WuSchool of Basic Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Guixian LinSchool of Basic Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Lixin ChenDepartment of Pharmacology and Department of Physiology, Medical College, Jinan University, Guangzhou, China.
Haifeng ZhangDepartment of Pharmacology and Department of Physiology, Medical College, Jinan University, Guangzhou, China.
Chunmei LiSchool of Basic Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Liwei WangDepartment of Pharmacology and Department of Physiology, Medical College, Jinan University, Guangzhou, China.
Jiayong ZhuGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Weizhang WangGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Fujiang ChuGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Juan ShenGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Hongzhi LiSchool of Basic Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Jianwen MaoGuangdong Key Laboratory for Bioactive Drugs Research, Guangdong Pharmaceutical University, Guangzhou, China.
Guangdong Pharmaceutical University · CNJinan University · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chloride channel-3 (ClC-3) protein is known to be a component of Cl- channels involved in cell volume regulation or acidification of intracellular vesicles. Here, we report that ClC-3 was highly expressed in the cytoplasm of metastatic carcinomatous cells and accelerated cell migration in vitro and tumor metastasis in vivo. High-grade expression of cytoplasmic ClC-3 predicted poor survival in cancer patients. We found that independent of its volume-activated Cl- channel properties, ClC-3 was able to promote cell membrane ruffling, required for tumor metastasis. ClC-3 mediated membrane ruffling by regulating keratin 18 phosphorylation to control β1 Integrin recycling. Therefore, cytoplasmic ClC-3 plays an active and key role in tumor metastasis and may be a valuable prognostic biomarker and a therapeutic target to prevent tumor spread.

Indexed as

AnimalsBiomarkers, TumorCell Line, TumorCell MembraneCell MovementChloride ChannelsCytoplasmHeLa CellsHumansImmunoblottingIntegrin beta1Kaplan-Meier EstimateKeratin-18Mice, TransgenicMicroscopy, ConfocalNeoplasm MetastasisBiomarkers, TumorChloride ChannelsClC-3 channelIntegrin beta1Keratin-18

Identifiers

PMID25537517
PMCPMC4385862
OpenAlexW1498381972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.